House Panel To Review Express Scripts' $29B Medco Buy

Law360, San Diego (September 13, 2011, 9:16 PM EDT) -- A House panel on Tuesday set a Sept. 20 hearing to examine Express Scripts Inc.’s proposed $29.1 billion acquisition of rival Medco Health Solutions Inc. as federal regulators continue to investigate whether the deal complies with antitrust laws.

The House Judiciary subcommittee on intellectual property, competition and the Internet is scheduled to review the transaction that aims to combine the largest and third-largest pharmacy benefits managers.

The subcommittee's website has not yet posted a list of witnesses for the hearing. Representatives for the companies were not...
To view the full article, register now.